Loading organizations...
Loading organizations...
Clinical-stage biotech improving outcomes in cardiothoracic surgery.
Renibus Therapeutics has raised $167.0M across 4 funding rounds.
Renibus Therapeutics has raised $167.0M in total across 4 funding rounds.
Renibus Therapeutics has raised $167.0M in total across 4 funding rounds.
Renibus Therapeutics's investors include Oxford Finance.
Renibus Therapeutics has raised $167.0M across 4 funding rounds. Most recently, it raised $72.0M Series B Extension in September 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 13, 2023 | $72.0M Series B Extension | ||
| Jul 19, 2023 | $47.0M Series B | ||
| Nov 15, 2022 | $33.0M Debt / Other Equity | Oxford Finance | |
| Feb 21, 2022 | $15.0M Series A Extension |